Market Overview

Benzinga's Top Upgrades, Downgrades For February 16, 2017

Share:
Related HSY
The Best Performing Component Of The S&P 500 Since It Was Born 60 Years Ago
Wall Street's M&A Chatter From March 8
Susquehanna analyzes developments at Hershey (Seeking Alpha)
Related DVN
Earnings Scheduled For February 14, 2017
Watch These 10 Huge Put Purchases In Thursday Trade
OPEC cuts lift Canadian oil sands prices relative to lighter grades (Seeking Alpha)

Top Upgrades

  • Analysts at Argus Research upgraded Hershey Co (NYSE: HSY) from Hold to Buy. Hershey shares rose 0.42 percent to close at $108.80 on Wednesday.
  • Analysts at Societe Generale upgraded Devon Energy Corp (NYSE: DVN) from Hold to Buy. Devon Energy shares rose 0.66 percent to $44.52 in pre-market trading.
  • Analysts at Jefferies upgraded MDC Partners Inc (NASDAQ: MDCA) from Hold to Buy. MDC Partners shares rose 4.62 percent to $9.05 in pre-market trading.
  • Wells Fargo upgraded Chimera Investment Corporation (NYSE: CIM) from Underperform to Market Perform. Chimera Investment shares fell 0.77 percent to close at $17.99 on Wednesday.
  • Analysts at Oppenheimer upgraded SunPower Corporation (NASDAQ: SPWR) from Perform to Outperform. SunPower shares fell 4.69 percent to $6.91 in pre-market trading.
  • Bank of America upgraded Cavium Inc (NASDAQ: CAVM) from Neutral to Buy. Cavium shares rose 0.72 percent to close at $65.50 on Wednesday.
  • Analysts at William Blair upgraded NetApp Inc. (NASDAQ: NTAP) from Underperform to Market Perform. NetApp shares rose 6.34 percent to $41.40 in pre-market trading.
  • Macquarie upgraded Bank of America Corp (NYSE: BAC) from Neutral to Outperform. RH shares gained 0.12 percent to $24.61 in pre-market trading.


Top Downgrades

  • Wedbush downgraded Groupon Inc (NASDAQ: GRPN) from Outperform to Neutral. Groupon shares fell 2.16 percent to $4.54 in pre-market trading.
  • Summit Redstone Partners downgraded Godaddy Inc (NYSE: GDDY) from Buy to Hold. GoDaddy shares fell 5.82 percent to $35.28 in pre-market trading.
  • Wells Fargo downgraded Analog Devices, Inc. (NASDAQ: ADI) from Outperform to Market Perform. Analog Devices shares gained 4.83 percent to close at $81.60 on Wednesday.
  • Stifel Nicolaus downgraded Molina Healthcare, Inc. (NYSE: MOH) from Buy to Hold. Molina Healthcare shares fell 17 percent to $49.70 in pre-market trading.
  • Morgan Stanley downgraded Taubman Centers, Inc. (NYSE: TCO) from Overweight to Equal-Weight. Taubman Centers shares fell 0.23 percent to close at $68.27 on Wednesday.
  • Citigroup downgraded Tower International Inc (NYSE: TOWR) from Buy to Neutral. Tower International shares rose 4.28 percent to close at $28.00 on Wednesday.
  • Analysts at Roth Capital downgraded Angie's List Inc (NASDAQ: ANGI) from Neutral to Sell. Angie's List shares fell 2.44 percent to $5.60 in pre-market trading.
  • Analysts at Credit Suisse downgraded Blackhawk Network Holdings Inc (NASDAQ: HAWK) from Outperform to Neutral. Blackhawk Network shares fell 8.97 percent to $34.00 in pre-market trading.
  • Bank of America downgraded Integrated Device Technology Inc (NASDAQ: IDTI) from Buy to Neutral. Integrated Device shares dropped 2.4 percent to $24.51 in pre-market trading.
  • Analysts at Susquehanna downgraded Kraft Heinz Co (NASDAQ: KHC) from Positive to Neutral. Kraft Heinz shares declined 2.84 percent to $88.51 in pre-market trading.


Top Initiations

  • Analysts at Wells Fargo initiated coverage on Communications Sales & Leasing Inc (NASDAQ: CSAL) with an Outperform rating. Communications Sales & Leasing shares closed at $26.39 on Wednesday.
  • Analysts at Ladenburg Thalmann initiated coverage on BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) with a Buy rating. The price target for BioCryst Pharmaceuticals is set to $11. BioCryst Pharmaceuticals shares closed at $6.16 on Wednesday.
  • Analysts at Needham initiated coverage on salesforce.com, inc. (NYSE: CRM) with a Hold rating. salesforce.com shares closed at $81.67 on Wednesday.
  • Analysts at Ladenburg Thalmann initiated coverage on Albireo Pharma, Inc. (NASDAQ: ALBO) with a Buy rating. The price target for Albireo Pharma is set to $40. Albireo Pharma shares closed at $20.28 on Wednesday.
  • Analysts at National Securities initiated coverage on Aqua Metals Inc (NASDAQ: AQMS) with a Buy rating. Aqua Metals shares closed at $16.94 on Wednesday.
  • Analysts at Seaport Global Securities initiated coverage of Science Applications International Corp (NYSE: SAIC) with a Buy rating. SAIC shares closed at $86.36 on Wednesday.
  • Analysts at Citi resumed coverage of Berry Plastics Group Inc (NYSE: BERY) with a Buy rating. Berry Plastics shares closed at $49.62 on Wednesday.

Latest Ratings for HSY

DateFirmActionFromTo
Feb 2017Societe GeneraleUpgradesSellHold
Feb 2017Argus ResearchUpgradesHoldBuy
Feb 2017Deutsche BankInitiates Coverage OnHold

View More Analyst Ratings for HSY
View the Latest Analyst Ratings

Posted-In: Downgrades Initiations top upgradesUpgrades Downgrades Initiation Analyst Ratings

 

Related Articles (ADI + ALBO)

View Comments and Join the Discussion!